Hypertrophy: Clinical Trials

6 trials for Hypertrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Unknown 6

Follow Hypertrophy: new trials by email Literature Review of Hypertrophy trials Research Report on Hypertrophy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension
Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI - Hypertension, Atrial Fibrillation
Phase 4UnknownBeijing Tsinghua Chang Gung Hospital4002023-06-012023-05-03
Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
sacubitril/valsartan, Amlodipine - Hypertension, Left Ventricular Hypertrophy
Phase 4UnknownShanghai Jiao Tong University School of Medicine1202021-11-282023-04-12
Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study
Everolimus - Left Ventricular Hypertrophy
Phase 4UnknownInstituto de Urologia e Nefrologia502015-07-012015-07-09
Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
Aliskiren, Eplerenone - Hypertensive Left Ventricular Hypertrophy
Phase 4UnknownNagoya University1002013-04-012013-07-22
Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery
Lovaza group - Mitral Valve Regurgitation, Left Atrium Dilatation and Hypertrophy
Phase 4UnknownEast Carolina University242010-01-012013-09-10
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
pegvisomant - Acromegaly, Heart Failure
Phase 4UnknownUniversity of Wuerzburg42006-06-012010-09-24

Narrower conditions

Hypertrophy, Left Ventricular (5)  ·  Hypertension (3)  ·  Acromegaly (1)  ·  Atrial Fibrillation (1)  ·  Cardiomegaly (1)  ·  Heart Failure (1)  ·  Mitral Valve Insufficiency (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Pathological Conditions, Anatomical (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Cardiomegaly (4)  ·  Vascular Diseases (3)  ·  Arrhythmias, Cardiac (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Heart Valve Diseases (1)  ·  Hyperpituitarism (1)

Interventions

Amlodipine (1)  ·  Eplerenone (1)  ·  Everolimus (1)  ·  aliskiren (1)  ·  azilsartan (1)  ·  pegvisomant (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)

Sponsors

Beijing Tsinghua Chang Gung Hospital (1)  ·  East Carolina University (1)  ·  Instituto de Urologia e Nefrologia (1)  ·  Nagoya University (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University of Wuerzburg (1)

Countries

China (2)  ·  Brazil (1)  ·  Germany (1)  ·  Japan (1)  ·  United States (1)

Top investigators

Bruno Allolio, MD (1)  ·  Ethan J Anderson, PhD (1)  ·  He Rong, M.D., Ph.D (1)  ·  Toyoaki Murohara, MD, PhD (1)